The company was established in Europe in Germany. The main department of described Corporate Investor is located in the Munich.
The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Medicis Capital, startups are often financed by Nexus Medical Partners, Innoven Partners, Ventech. The meaningful sponsors for the fund in investment in the same round are Ventech, Saratoga Ventures, Nexus Medical Partners. In the next rounds fund is usually obtained by Valiance Asset Management, Accuitive Medical Ventures, Yorkville Advisors.
The top activity for fund was in 2010. The usual things for fund are deals in the range of 10 - 50 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The typical startup value when the investment from Medicis Capital is 100-500 millions dollars. This Medicis Capital works on 38 percentage points more the average amount of lead investments comparing to the other organizations. Speaking about the real fund results, this Corporate Investor is 13 percentage points more often commits exit comparing to other organizations. The higher amount of exits for fund were in 2019.
The fund has exact preference in a number of founders of portfolio startups. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. Among the various public portfolio startups of the fund, we may underline Hybrigenics, EyeGate Pharmaceuticals, MyoScience Among the most popular fund investment industries, there are Health Diagnostics, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund.
Related Funds
Funds with similar focus
Fund Name | Location |
Beijing Shiji Beiguang Advertising Co | - |
Btwinz Ventures | France, Ile-de-France, Paris |
Dinghongxin Asset Management | China, Guangdong, Shenzhen |
EdsLink | New York, New York, United States |
inpro | Berlin, Berlin, Germany |
ItalBank International | Puerto Rico, San Juan, United States |
Jiade Touzi | - |
MasterCard | New York, Purchase, United States |
Phoenix Fortune Group | Beijing, Beijing, China |
Pivotal bioVenture Partners China | China, Shanghai |
Prodways | France, Ile-de-France, Paris |
South West Angel and Investor Network (Swain) | Bristol, England, United Kingdom |
Stobart Group | England, Germany, Nordrhein-Westfalen |
Sunner Capital | - |
Thinktiv | Austin, Texas, United States |
UTA Ventures | Beverly Hills, California, United States |
Notable deals
Company | Industry | Round Size | Date | Investors | Location |
EyeGate Pharmaceuticals | $15M | 12 Mar 2008 | Massachusetts, United States | ||
Hybrigenics | $15M | 01 Dec 2001 | Paris, Ile-de-France, France |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Latest deals
Company | Industry | Round Size | Date | Investors | Location |
EyeGate Pharmaceuticals | $15M | 12 Mar 2008 | Massachusetts, United States | ||
Hybrigenics | $15M | 01 Dec 2001 | Paris, Ile-de-France, France |